GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
7V0K | Q02094 | Consensus refinement of human erythrocyte ankyrin-1 complex (Composite map) | |
7V0K | P02730 | Consensus refinement of human erythrocyte ankyrin-1 complex (Composite map) | |
7V0K | P16452 | Consensus refinement of human erythrocyte ankyrin-1 complex (Composite map) | |
1WLW | Q9YIC2 | Congerin II Y16S single mutant | |
1WLD | Q9YIC2 | Congerin II T88I single mutant | |
3O8T | Q16539 | Conformational plasticity of p38 MAP kinase DFG-motif mutants in response to inhibitor binding | |
3OBJ | Q16539 | Conformational plasticity of p38 MAP kinase DFG mutants in response to inhibitor binding | |
3MPA | Q16539 | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | |
3O8P | Q16539 | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | |
3O8U | Q16539 | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | |
2CEK | P04058 | Conformational Flexibility in the Peripheral Site of Torpedo californica Acetylcholinesterase Revealed by the Complex Structure with a Bifunctional Inhibitor | |
8H3N | P0DTC2 | Conformation 2 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab | |
8H3N | 8H3N | Conformation 2 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab | |
8H3M | P0DTC2 | Conformation 1 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab | |
8H3M | 8H3M | Conformation 1 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab | |
7DWX | Q695T7 | Conformation 1 of S-ACE2-B0AT1 ternary complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7DWX | Q9BYF1 | Conformation 1 of S-ACE2-B0AT1 ternary complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7DWX | P0DTC2 | Conformation 1 of S-ACE2-B0AT1 ternary complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7MGD | P02866 | Concanavalin A bound to a DNA glycoconjugate, T(Man-T)TT | |
7MG7 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-GTAC | |
7MG8 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-CGCG | |
7MG5 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-ATAT | |
7MG6 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AGCT | |
7MGA | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AAATTT | |
7MGC | P02866 | Concanavalin A bound to a DNA glycoconjugate, G(Man-T)AC | |
7MGB | P02866 | Concanavalin A bound to a DNA glycoconjugate, A(Man-T)AT | |
7MG9 | P02866 | Concanavalin A bound to DNA glycoconjugates, Man-TTTT and Man-AAAA | |
3D4K | P02866 | Concanavalin A Complexed to a Synthetic Analog of the Trimannoside | |
6VEQ | A0A0B5AC95 | Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEQ | A0A0B5A8Q2 | Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEQ | 6VEQ | Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEQ | P06213 | Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6OB5 | A0A2Y0TBT9 | Computationally-designed, modular sense/response system (S3-2D) | |
6OB5 | 6OB5 | Computationally-designed, modular sense/response system (S3-2D) | |
5VLI | P03452 | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
5VLI | 5VLI | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
6OB0 | P06858 | Compound 2 bound structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells | |
6OB0 | Q8IV16 | Compound 2 bound structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells | |
8CS9 | P16157 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
8CS9 | P18577 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
8CS9 | Q02094 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
8CS9 | P06028 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
8CS9 | P02724 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
8CS9 | P02730 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
8CS9 | P16452 | Composite reconstruction of Class 1 of the erythrocyte ankyrin-1 complex | |
6Z7P | P35828 | Composite model of the Caulobacter crescentus S-layer bound to the O-antigen of lipopolysaccharide | |
6T6C | Q91159 | Complex with chitin oligomer of C-type lysozyme from the upper gastrointestinal tract of Opisthocomus hoatzin | |
5XUG | A0A0A1NDE2 | Complex structure(RmMan134A-M5). | |
5NXU | E3U904 | Complex structure with maltose of Providencia stuartii Omp-Pst1 porin | |
6RJO | A0A2I4PGZ0 | Complex structure of virulence factor SghA with its substrate analog salicin |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024